Tag: glagov

November 15, 2016/Research

First IVUS Study of a PCSK9 Inhibitor Shows Atheroma Regression at Unprecedented LDL-C Levels

GLAGOV results boost hopes for coming outcome trials

BackPage 1 of 1Next

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy